How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Orthopaedic Casting Tapes Market
- By Material Type: Fiberglass Casting Tape, Plaster of Paris Casting Tape, Synthetic Casting Tape
- By Product Form: Rolls, Pre-cut Strips, Sheets
- By End User: Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, Emergency Care Centers
- By Application: Fracture Immobilization, Post-Surgical Support, Orthopedic Injury Management, Sports Injury Treatment
- By Price Range: Economy, Mid-Range, Premium
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Fiberglass Casting Tape leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 287 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.173 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.181 →
Full report · locked preview
Everything inside the Orthopaedic Casting Tapes Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Material Type 3
Product Form 3
End User 4
Application 4
Price Range 3
Companies profiled
3M Company
Johnson & Johnson (DePuy Synthes)
BSN Medical (Essity)
Nexcare (3M)
Andover Healthcare
Scapa Group plc
Tynor Orthotics
Medi USA
Lohmann & Rauscher
Smith & Nephew
BSN Medical
Surgitech
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →3M Company
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Johnson & Johnson (DePuy Synthes)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BSN Medical (Essity)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nexcare (3M)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Andover Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Scapa Group plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Tynor Orthotics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Medi USA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Lohmann & Rauscher
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Smith & Nephew
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →BSN Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Surgitech
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →DJO Global
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Sam Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Hollister Incorporated
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,232M by 2033 · 4.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Fiberglass Casting Tape57.6
- Plaster of Paris Casting Tape27.9
- Synthetic Casting Tape14.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$284.5M → $448.6M · 5.9%
Europe$198.3M → $312.1M · 5.8%
Asia Pacific$181.1M → $256.6M · 4.5%
Latin America$112.1M → $171.3M · 5.4%
Middle East and Africa$86.2M → $110.4M · 3.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.512026
4.532027
4.532028
4.552029
4.552030
4.582031
4.582032
4.602033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- 3M Company10.9
- Johnson & Johnson (DePuy Synthes)19.2
- BSN Medical (Essity)12.1
- Nexcare (3M)10.8
- Andover Healthcare7.0
- Scapa Group plc12.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type26.8%
Product Form21.6%
End User23.0%
Application15.5%
Price Range13.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.5
- Europe24.0
- Asia Pacific19.7
- Latin America13.2
- Middle East and Africa8.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| 3M Company | 81 | 74 | 91 | 84 | 75 | 96 | 84 |
| Johnson & Johnson (DePuy Synthes) | 78 | 70 | 71 | 87 | 79 | 83 | 78 |
| BSN Medical (Essity) | 84 | 86 | 79 | 67 | 86 | 70 | 79 |
| Nexcare (3M) | 80 | 57 | 62 | 76 | 67 | 77 | 70 |
| Andover Healthcare | 72 | 70 | 64 | 66 | 59 | 51 | 64 |
| Scapa Group plc | 62 | 54 | 60 | 57 | 62 | 54 | 58 |
| Tynor Orthotics | 50 | 42 | 47 | 59 | 53 | 62 | 52 |
| Medi USA | 47 | 51 | 38 | 47 | 40 | 47 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- 3M Company
- Johnson & Johnson (DePuy Synthes)
- BSN Medical (Essity)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| 3M Company | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Johnson & Johnson (DePuy Synthes) | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| BSN Medical (Essity) | ✓ | ✓ | ✓ | ◐ | ✓ | − |
| Nexcare (3M) | ◐ | − | ◐ | ✓ | ◐ | ✓ |
| Andover Healthcare | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| Scapa Group plc | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Tynor Orthotics | ◐ | − | ◐ | ◐ | − | ◐ |
| Medi USA | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →13M Company84
2BSN Medical (Essity)79
3Johnson & Johnson (DePuy Synthes)78
4Nexcare (3M)70
5Andover Healthcare64
6Scapa Group plc58
7Tynor Orthotics52
8Medi USA45
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
3M CompanyJohnson & Johnson (DePuy Synthes)BSN Medical (Essity)
Challenger1
Strong scale, closing on the leaders.
Nexcare (3M)
Contender2
Focused players with pockets of strength.
Andover HealthcareScapa Group plc
Niche2
Specialists in a single segment or region.
Tynor OrthoticsMedi USA
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Type in North America, then scale across Orthopaedic Casting Tapes Market — a $285M beachhead inside a $4.30B market.
Beachhead (SOM)$285Mobtainable near-term
Serviceable (SAM)$1.67Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Fiberglass Casting Tape
Best fit — highest urgency & budget in Material Type.
Economic buyer80 fit
Plaster of Paris Casting Tape
Strong fit — clear ROI and a fast path to value.
End user65 fit
Synthetic Casting Tape
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Product Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel26%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Orthopaedic Casting Tapes Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified25%
Evaluation13%
Closed-won6%
$20.4KCAC
$100KLTV
4.9:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Orthopaedic Casting Tapes Market is a resilient opportunity — $5.37B by 2033, compounding at 4.7%.
TAM · 2025$3.72Btoday
TAM · 2033$5.37Bforecast
CAGR4.7%2027–2033
Cumulative$40.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.37BTotal addressable market
SAM$1.89BServiceable available market
SOM$335MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.7% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.37BLarge & growingTAM by 2033 at 4.7% CAGR
$1.89BServiceable nowreachable with today’s model
$335MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.19BBear3.0% CAGR
$5.37BBase4.7% CAGR
$6.87BBull6.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Product Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Orthopaedic Casting Tapes Market — a $2.08B market by 2033. Plan: grow share from 7.2% to 14.3%.
Market size · 2033$2.08Btotal addressable
Market CAGR3.8%2027–2033
Target share14.3%from 7.2% today
Revenue ambition$298Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.2% | 14.3% | On track |
| Revenue | $158M | $298M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 35.0% | 43.5% | On track |
| Customer retention | 88.7% | 96.6% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Product Form capability
A defensible second engine — invest in Product Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Product Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $43M capacity & capability investment
- Greenlight bolt-on M&A in Product Form
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossBehind
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Orthopaedic Casting Tapes Market conversation — a $6.79B market you can size, segment and defend in minutes.
Market size · 2033$6.79Btotal opportunity
Growth11.4%CAGR to 2033
Addressable buyers1,610+accounts in scope
Typical ROI4.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.9×return on cost, year one
< 3 mopayback period
$80K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
3M CompanyJohnson & Johnson (DePuy Synthes)BSN Medical (Essity)Nexcare (3M)Andover HealthcareScapa Group plcTynor OrthoticsMedi USA+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Orthopaedic Casting Tapes Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Orthopaedic Casting Tapes Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Orthopaedic Cable System Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportOrthopaedic Bionics Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportOrtho-k Overnight Contact Lenses Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportOrtho-K Lens Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportOrtho-k Lens for Vision Correction Market
Market size, share, segmentation and regional forecast.
$676M market · 2025 base year
View reportOrtho-K Lenses for Children and Teenagers Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportOrthokeratology Lens Materials Market
Market size, share, segmentation and regional forecast.
$859M market · 2025 base year
View reportOrtho-K Contact Lenses Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportOrthodontic Wire Cutters Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportOrthodontic Treatment Product Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportOrthodontic Treatment Brace Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportOrthodontic Treatment Appliances Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.